Whitepaper: Supporting the Advancement of Drug-Eluting Devices

Presenting alternative methods for addition of API to silicone components for drug-eluting medical devices
 
Drug device combination products are increasingly being used in the treatment and control of medical conditions, as they offer several advantages when compared with drug delivery via oral, injection, and infusion methods. For this reason, drug-eluting medical device products have seen a surge in development, in particular those that elute regular controlled doses of drugs precisely and consistently to a treatment area.
 
In this whitepaper, we take a closer look at:

Silicone and its role in combination products, in particular implantable medical devices
The immersion-impregnation method for producing drug device combination products
Methods for adding the Active Pharmaceutical Ingredient (API) to silicone